Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: Cross-sectional and retrospective longitudinal studies

Schizophrenia Research

Volumn 59, Issue 2-3, 2003, Pages 147-157

  Higashima, Masato ^a   Nagasawa, Tatsuya ^a   Kawasaki, Yasuhiro ^b   Oka, Takashi ^a   Sakai, Naoto ^a   Tsukada, Takahiro ^a   Koshino, Yoshifumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Auditory oddball task; Event related potential; P300; Positive symptom; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HUMAN; LEFT HEMISPHERE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SYMPTOM; TEMPORAL LOBE;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CHLORPROMAZINE; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 0037290143     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00397-8     Document Type: Article

References (44)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. edn. 1987;American Psychiatric Press, Washington, DC.
2. Barta P.E., Pearlson G.D., Powers R.E., Richards S.S., Tune L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiatry. 147:1990;1457-1462.
3. Blackwood D. P300, a state and a trait marker in schizophrenia. Lancet. 355:2000;771-772.
4. Blackwood D.H.R., Whalley L.J., Christie J.E., Blackburn I.M., St. Clair D.M., McInnes A. Changes in auditory P3 event-related potential in schizophrenia and depression. Br. J. Psychiatry. 150:1987;154-160.
5. Blackwood D.H.R., St. Clair D.M., Muir W.J., Duffy J.C. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch. Gen. Psychiatry. 48:1991;899-909.
6. Bogerts B., Lieberman J.A., Ashtari M., Bilder R.M., Degreef G., Lerner G., Johns C., Masiar S. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol. Psychiatry. 33:1993;236-246.
7. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 19:1993;233-259.
8. Chua S.E., Wright I.C., Poline J.B., Liddle P.F., Murray R.M., Frackowiak R.S., Friston K.J., McGuire P.K. Gray matter correlates of syndromes in schizophrenia. A semi-automated analysis of structural magnetic resonance images. Br. J. Psychiatry. 170:1997;406-410.
9. Duncan C.C., Morihisa J.M., Fawcett R.W., Kirch D.G. P300 in schizophrenia: state or trait marker? Psychopharmacol. Bull. 23:1987;497-501.
10. Egan M.F., Duncan C.C., Suddath R.L., Kirch D.G., Mirsky A.F., Wyatt R.J. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia. Schizophr. Res. 11:1994;259-271.
11. Eikmeier G., Lodemann E., Zerbin D., Gastpar M. P300, clinical symptoms, and neuropsychological paramaters in acute and remitted schizophrenia: a preliminary report. Biol. Psychiatry. 31:1992;1065-1069.
12. Ford J.M., Sullivan E.V., Marsh L., White P.M., Lim K.O., Pfefferbaum A. The relationship between P300 amplitude and regional gray matter volumes depends upon the attentional system engaged. Electroencephalogr. Clin. Neurophysiol. 90:1994;214-228.
13. Ford J.M., White P.M., Csernansky J.G., Faustman W.O., Roth W.T., Pfefferbaum A. ERPs in schizophrenia: effects of antipsychotic medication. Biol. Psychiatry. 36:1994;153-170.
14. Ford J.M., Mathalon D.H., Marsh L., Faustman W.O., Harris D., Hoff A.L., Beal M., Pfefferbaum A. P300 amplitude is related to clinical state in severely and moderately ill patients with schizophrenia. Biol. Psychiatry. 46:1999;94-101.
15. Frangou S., Sharma T., Alarcon G., Sigmudsson T., Takei N., Binnie C., Murray R.M. The Maudsley family study: II. Endogenous event-related potentials in familial schizophrenia. Schizophr. Res. 23:1997;45-53.
16. Frodl-Bauch T., Gallinat J., Meisenzahl E.-M., Möller H.-J., Hegerl U. P300 subcomponents reflect different aspects of psychopathology in schizophrenia. Biol. Psychiatry. 45:1999;116-126.
17. Halgren E., Marinkovic K., Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr. Clin. Neurophysiol. 106:1998;156-164.
18. Higashima M., Urata K., Kawasaki Y., Maeda Y., Sakai N., Mizukoshi C., Nagasawa T., Kamiya T., Yamaguchi N., Koshino Y. P300 amplitude and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biol. Psychiatry. 44:1998;115-120.
19. Iwanami A., Okajima Y., Kuwakado D., Isono H., Kasai K., Hata A., Nakagome K., Fukuda M., Kamijima K. Event-related potentials and thought disorder in schizophrenia. Schizophr. Res. 42:2000;187-191.
20. Juckel G., Müller-Schubert A., Gaebel W., Hegerl U. Residual symptoms and P300 in schizophrenic outpatients. Psychiatry Res. 65:1996;23-32.
21. Kameyama T., Niwa S., Hiramatsu K., Saito O. Hand preference and eye dominance patterns in schizophrenics and affective disorders. Seishin Igaku. 23:1981;1271-1274.
22. Kaplan R.D., Szechtman H., Franco S., Szechtman B., Nahmias C., Garnett E.S., List S., Cleghorn J.M. Three clinical syndromes of schizophrenia in untreated subjects: relation of brain glucose activity measured by positron emission tomography (PET). Schizophr. Res. 11:1993;47-54.
23. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13:1987;261-276.
24. Kidogami Y., Yoneda H., Adaba H., Sakai T. P300 in first degree relatives of schizophrenics. Schizophr. Res. 6:1992;9-13.
25. Knight R.T., Scabini D., Woods D.L., Clayworth C.C. Contributions of temporal-parietal junction to the human auditory P3. Brain Res. 502:1989;109-116.
26. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., Frackowiak R.S.J. Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatry. 160:1992;179-186.
27. Mathalon D.H., Ford J.M., Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol. Psychiatry. 47:2000;434-449.
28. Mathalon D.H., Sullivan E.V., Lim K.L., Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men. Arch. Gen. Psychiatry. 58:2001;148-157.
29. McCarley R.W., Faux S.F., Shenton M., LeMay M., Cane M., Ballinger R., Duffy F.H. CT abnormalities in schizophrenia: a preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms. Arch. Gen. Psychiatry. 46:1989;698-708.
30. McCarley R.W., Shenton M.E., O'Donnell B.F., Faux S.F., Kikinis R., Nestor P.G., Jolesz F.A. Auditory P300 abnormalities and left posterior temporal gyrus volume reduction in schizophrenia. Arch. Gen. Psychiatry. 50:1992;190-197.
31. Nagasawa T., Kamiya T., Kawasaki Y., Higashima M., Urata K., Sakai N., Koshino Y. The relationship between auditory ERP and neuropsychological assessments in schizophrena. Int. J. Psychophysiol. 34:1999;267-274.
32. Pfefferbaum A., Rosenbloom M.J. Skull thickness influences P3 amplitude. Psychopharmacol. Bull. 23:1987;493-496.
33. Pfefferbaum A., Ford J.M., White P.M., Roth W.T. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms. Arch. Gen. Psychiatry. 46:1989;1035-1044.
34. Posner M.I. Psychobiology of attention. Bazaniga M.S., Blackmore C. Handbook of Psychobiology. 1975;441-480 Academic Press, New York.
35. Pritchard W.S. Cognitive event-related potential correlates of schizophrenia. Psychol. Bull. 100:1986;43-66.
36. Roth W.T., Cannon E.H. Some features of the auditory evoked response in schizophrenics. Arch. Gen. Psychiatry. 27:1972;466-471.
37. Roxborough H., Muir W.J., Blackwood D.H.R., Walker M.T., Blackburn I.M. Neuropsychological and P300 abnormalities in schizophrenics and their relatives. Psychol. Med. 23:1993;305-314.
38. Saykin A., Gur R.C., Gur R.E., Mozley D.L.H., Resnick S.M., Kester D.B., Stafiniak P. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch. Gen. Psychiatry. 48:1991;618-624.
39. Schröder J., Buchsbaum M.S., Siegel B.V., Geider F.J., Lohr J., Tang C., Wu J., Potkin S.G. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr. Res. 19:1996;41-53.
40. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., McCarley R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N. Engl. J. Med. 327:1992;604-612.
41. Spitzer R., Williams J., Gibbon M., First M. Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). 1988;New York State Psychiatric Institute Biometrics Department, New York.
42. Strik W.K., Dierks T., Maurer K. Amplitudes of auditory P300 in remitted and residual schizophrenics: correlations with clinical features. Neuropsychobiology. 27:1993;54-60.
43. Turetsky B., Colbath E.A., Gur R.E. P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stability and relationship to symptom change. Biol. Psychiatry. 43:1998;31-39.
44. Wright I.C., McGuire P.K., Poline J.B., Travere J.M., Murray R.M., Frith C.D., Frackowiak R.S., Friston K.J. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimaging. 2:1995;244-252.